| dc.contributor.author | Matthews, P. | |
| dc.contributor.author | Sartor, A. O. | |
| dc.contributor.author | De Bono, J. S. | |
| dc.contributor.author | Oudard, S. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Hansen, S. | |
| dc.contributor.author | Machiels, J. H. | |
| dc.contributor.author | Shen, L. | |
| dc.date.accessioned | 2021-03-03T09:31:40Z | |
| dc.date.available | 2021-03-03T09:31:40Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | De Bono J. S. , Oudard S., Ozguroglu M., Hansen S., Machiels J. H. , Shen L., Matthews P., Sartor A. O. , "Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC)", JOURNAL OF CLINICAL ONCOLOGY, cilt.28, sa.15, 2010 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_1d6c2847-016b-4bbc-b33b-d7c83857a9cb | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/24968 | |
| dc.identifier.uri | https://doi.org/10.1200/jco.2010.28.15_suppl.4508 | |
| dc.language.iso | eng | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.title | Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC) | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 28 | |
| dc.identifier.issue | 15 | |
| dc.contributor.firstauthorID | 196151 | |
